Omnicell, Inc. (OMCL) vs Schrodinger, Inc. (SDGR)
- Omnicell, Inc. OMCL 35.39 −1.56%
- Schrodinger, Inc. SDGR 22.60 −11.30%
Omnicell, Inc. and Schrodinger, Inc. are both Health Information Services companies. Schrodinger, Inc. is the larger, with a market value of $1.9B against $1.6B — 1.2× the size. Schrodinger, Inc. has negative trailing earnings, so its P/E is not meaningful; Omnicell, Inc. trades at 41.6×. Schrodinger, Inc. grew revenue faster over the last twelve months: 8.88% against 8.45%. Omnicell, Inc. has the higher net margin (3.13% vs −21.0%) and the higher return on invested capital (3.10% vs 0.00%). Across the 19 metrics below, Omnicell, Inc. leads on 12 and Schrodinger, Inc. on 7.
Valuation
Profitability
| Metric | OMCL | SDGR | Health Information Services median |
|---|---|---|---|
| Gross margin | 44.77% | 56.87% | 62.87% |
| Operating margin | 4.65% | (59.24%) | (9.45%) |
| Net margin | 3.13% | (20.98%) | (15.48%) |
| Free cash flow margin | 10.17% | (50.29%) | 0.00% |
| Return on equity | 3.06% | (16.18%) | (6.91%) |
| Return on assets | 1.89% | (8.18%) | (6.28%) |
| Return on invested capital | 3.10% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack